01201nas a2200217   4500000000100000008004100001260000900042653002300051653001100074653002300085653001200108653002500120653001300145653003000158100001500188245008400203300001000287490000800297520066400305022001400969       1990                            d  c199010aBacterial Vaccines10aHumans10aLeprostatic Agents10aleprosy10aMycobacterium leprae10aResearch10aWorld Health Organization1 aKurlberg G00a[Research in developing countries: will leprosy vaccine be produced in Nepal?].  a338-90 v1053 a<p>Clinical, bacteriological and immunological research into leprosy is pursued at the Anandaban Leprosy Hospital on the outskirts of Kathmandu in Nepal with support from the World Health Organization and research laboratories in inter alia Holland and Australia. The bacteriological part consists of research into cultivation procedures on mice for diagnosis of Mycobacterium Leprae resistance to dapsone and rifampicin. Serological studies have also yielded M. Leprae-specific antibodies, a method which, it is hoped, will be further developed as an aid to diagnosis and follow-up of treatment. Research concerning a leprosy vaccine is also in progress.</p>  a0029-1420